Fatema Dhaif
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fatema Dhaif has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Metcalfe
Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK
2 shared publications - Alexander Thomas Schade
Affiliations Malawi-Liverpool-Wellcome Trust, Blantyre, Malawi, Liverpool School of Tropical Medicine, Liverpool, United Kingdom, Queen Elizabeth Central Hospital, Blantyre, Malawi
1 shared publication - Ali Ridha
South West London Elective Orthopaedic Center, Epsom, UK
1 shared publication Andrew Metcalfe
Warwick Clinical Trials Unit University of Warwick Coventry UK
1 shared publicationChetan Khatri
Warwick Clinical Trials Unit University of Warwick Coventry UK
1 shared publication- Chetan Khatri
Clinical Trials Unit, University of Warwick, Coventry, UK
1 shared publication
Latest Publications
- Open Access
Obesity and arthritis of the knee Study (OAKS): study protocol for a prospective cohort study examining the treatments and outcomes of people with obesity and severe knee arthritis
Introduction: People with body mass index (BMI) ≥35 kg/m 2 have an approximately 19-fold increased risk of undergoing total knee replacement (TKR); however, many UK integrated care boards (37%) have restrictive policies which limit access to TKR for people based on BMI. Therefore, access to both surgical and non-surgical treatments varies widely, exacerbating existing health inequalities. It remains unclear how decisions about offering TKR are made in people with severe knee osteoarthritis, which weight-loss interventions are provided in practice and how different management pathways relate to patient outcomes among individuals with high BMI. Methods and analysis: This study will recruit 400 participants with severe Kellgren-Lawrence grade four knee osteoarthritis from eight secondary care centres in England. All participants, irrespective of BMI, will provide baseline clinical data and patient-reported outcome measures (PROMs), enabling characterisation of baseline associations between BMI, knee function and body image. A prespecified subgroup of participants with BMI ≥35 kg/m 2 (minimum n=105) will undergo longitudinal follow-up at 6 months, 12 months and 24 months, including repeat BMI measurement, PROMs and detailed data on access to surgical and non-surgical interventions, including weight-loss strategies and TKR. For those with BMI ≥35 kg/m 2 , statistical modelling will be used to explore associations between baseline factors and longitudinal outcomes including Oxford Knee Score and weight change at 12 months (n≥105). Structural equation modelling will be used to quantify associations between BMI and knee pain/function mediated by psychosocial factors using data from all participants (n=400). A nested qualitative study of surgeons and patients will explore obstacles and preferences in the management of severe knee osteoarthritis. Ethics and dissemination: The study received ethical approval from the West of Scotland REC 5 (Ref: 24/WS/0146) on 10 October 2024. Results will be disseminated through peer-reviewed publications. Trial registration number: ISRCTN42984928 .
Open AccessObesity and arthritis of the knee Study (OAKS): study protocol for a prospective cohort study examining the treatments and outcomes of people with obesity and severe knee arthritis
Introduction: People with body mass index (BMI) ≥35 kg/m 2 have an approximately 19-fold increased risk of undergoing total knee replacement (TKR); however, many UK integrated care boards (37%) have restrictive policies which limit access to TKR for people based on BMI. Therefore, access to both surgical and non-surgical treatments varies widely, exacerbating existing health inequalities. It remains unclear how decisions about offering TKR are made in people with severe knee osteoarthritis, which weight-loss interventions are provided in practice and how different management pathways relate to patient outcomes among individuals with high BMI. Methods and analysis: This study will recruit 400 participants with severe Kellgren-Lawrence grade four knee osteoarthritis from eight secondary care centres in England. All participants, irrespective of BMI, will provide baseline clinical data and patient-reported outcome measures (PROMs), enabling characterisation of baseline associations between BMI, knee function and body image. A prespecified subgroup of participants with BMI ≥35 kg/m 2 (minimum n=105) will undergo longitudinal follow-up at 6 months, 12 months and 24 months, including repeat BMI measurement, PROMs and detailed data on access to surgical and non-surgical interventions, including weight-loss strategies and TKR. For those with BMI ≥35 kg/m 2 , statistical modelling will be used to explore associations between baseline factors and longitudinal outcomes including Oxford Knee Score and weight change at 12 months (n≥105). Structural equation modelling will be used to quantify associations between BMI and knee pain/function mediated by psychosocial factors using data from all participants (n=400). A nested qualitative study of surgeons and patients will explore obstacles and preferences in the management of severe knee osteoarthritis. Ethics and dissemination: The study received ethical approval from the West of Scotland REC 5 (Ref: 24/WS/0146) on 10 October 2024. Results will be disseminated through peer-reviewed publications. Trial registration number: ISRCTN42984928 .
- Open Access
- 1 October 2025
- Published by Wiley in Journal of Experimental Orthopaedics
- Vol. 12 (4) , e70537
Common intra‐articular knee injections demonstrate a similar recovery trajectory over 60 months: A systematic review and meta‐analysis of 15,418 participants
Purpose: To summarise the recovery trajectories of people undergoing intra‐articular knee injections in randomised‐controlled trials (RCTs) for osteoarthritis (OA) using patient‐reported outcome measures over time. Methods: A systematic review of published RCTs on intra‐articular knee injections with at least 100 participants enrolled and a minimum of 6‐month follow‐up was conducted. MEDLINE, Embase and Cochrane Central Register of Controlled Trials were searched until April 2025. A meta‐analysis of within‐arm response to treatments was calculated as the standardised mean change and 95% confidence interval (CI) at 1, 3, 6, 9, 12, 24 and 60 months by randomly selecting one arm from each study. Subgroup analyses were performed according to treatment received. The primary outcome measure included the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Secondary outcome measures included the visual analogue scale (VAS), Knee Osteoarthritis Outcome Score and International Knee Documentation Centre Score. Results: This study included 73 RCTs (15,418 participants). Pooled SMC for total WOMAC was −2.59 (95% CI: −4.35 to −0.84) at 1 month, −3.3 (95% CI: −5.10 to −1.50) at 3 months, −2.58 (95% CI: −3.95 to −1.20) at 6 months, −3.19 (95% CI: −7.18 to 0.79) at 9 months, −2.09 (95% CI: −3.50 to −0.67) at 12 months, −0.05 (95% CI: −1.43 to 1.34) at 24 months and 0.04 (95% CI: −1.50 to 1.59) at 60 months. Hyaluronic acid (HA), autologous blood product and steroid arms all showed a similar trend. A similar trend was seen for all subscores. Placebo or physiotherapy showed little improvement, except for in VAS pain for 6 months. Conclusion: People undergoing HA, autologous blood product and steroid injections demonstrated a consistent pattern in improvement. This may explain why existing meta‐analyses demonstrate inconsistencies in superior treatment. The lack of improvement in placebo or physiotherapy arms suggests regression to the mean is not evident. Clinical Trial: PROSPERO CRD42023445663. Level of Evidence: Level I.
- 1 October 2025
- Published by Wiley in Journal of Experimental Orthopaedics
- Vol. 12 (4) , e70537
Open AccessCommon intra‐articular knee injections demonstrate a similar recovery trajectory over 60 months: A systematic review and meta‐analysis of 15,418 participants
Purpose: To summarise the recovery trajectories of people undergoing intra‐articular knee injections in randomised‐controlled trials (RCTs) for osteoarthritis (OA) using patient‐reported outcome measures over time. Methods: A systematic review of published RCTs on intra‐articular knee injections with at least 100 participants enrolled and a minimum of 6‐month follow‐up was conducted. MEDLINE, Embase and Cochrane Central Register of Controlled Trials were searched until April 2025. A meta‐analysis of within‐arm response to treatments was calculated as the standardised mean change and 95% confidence interval (CI) at 1, 3, 6, 9, 12, 24 and 60 months by randomly selecting one arm from each study. Subgroup analyses were performed according to treatment received. The primary outcome measure included the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Secondary outcome measures included the visual analogue scale (VAS), Knee Osteoarthritis Outcome Score and International Knee Documentation Centre Score. Results: This study included 73 RCTs (15,418 participants). Pooled SMC for total WOMAC was −2.59 (95% CI: −4.35 to −0.84) at 1 month, −3.3 (95% CI: −5.10 to −1.50) at 3 months, −2.58 (95% CI: −3.95 to −1.20) at 6 months, −3.19 (95% CI: −7.18 to 0.79) at 9 months, −2.09 (95% CI: −3.50 to −0.67) at 12 months, −0.05 (95% CI: −1.43 to 1.34) at 24 months and 0.04 (95% CI: −1.50 to 1.59) at 60 months. Hyaluronic acid (HA), autologous blood product and steroid arms all showed a similar trend. A similar trend was seen for all subscores. Placebo or physiotherapy showed little improvement, except for in VAS pain for 6 months. Conclusion: People undergoing HA, autologous blood product and steroid injections demonstrated a consistent pattern in improvement. This may explain why existing meta‐analyses demonstrate inconsistencies in superior treatment. The lack of improvement in placebo or physiotherapy arms suggests regression to the mean is not evident. Clinical Trial: PROSPERO CRD42023445663. Level of Evidence: Level I.
- Open Access
- 29 October 2024
- Published by Springer Nature
What are the treatments and outcomes of people with obesity and severe knee osteoarthritis?
- 29 October 2024
- Published by Springer Nature
Open AccessWhat are the treatments and outcomes of people with obesity and severe knee osteoarthritis?
- Open Access
- 27 February 2024
- Published by SAGE Publications in Tropical Doctor
- Vol. 54 (3) , 272-281
A meta-analysis of the incidence of infections following open tibia fractures and the microorganisms that cause them in high-, middle- and low-income countries
Open tibia fractures are devastating, life changing injuries, with infection associated with substantial morbidity to the patient. Reducing infection is a research priority, but before interventional studies can be designed, the incidence of infection following this injury needs to be better defined. Our aim was to estimate the global incidence of infection following an open tibia fracture. A systematic review was performed of MEDLINE, EMBASE, Central Register of Controlled Trials (CENTRAL), Web of Science and Global Index Medicus. We included randomised controlled trials with more than ten participants which reported infections after open diaphyseal or distal fractures (AO 42 or 43). Primary outcome was deep infection according to the Centres for Disease Control and Prevention criteria. Secondary outcome included causative micro-organisms. A meta-analysis using a random effects model to assess incidence and between-treatment effects was performed. Thirteen studies including 1463 adults from seven middle-income countries, seven high-income countries and one low-income country were included. The incidence of infection was 12.12 person-years (95% CI 7.95–18.47). A subgroup analysis compared external fixation and intramedullary nailing showed no difference between infection rates. There were limited data on organisms, but Staphylococcus aureus was the most commonly identified. There are limited to no data on antimicrobial resistance.
- 27 February 2024
- Published by SAGE Publications in Tropical Doctor
- Vol. 54 (3) , 272-281
Open AccessA meta-analysis of the incidence of infections following open tibia fractures and the microorganisms that cause them in high-, middle- and low-income countries
Open tibia fractures are devastating, life changing injuries, with infection associated with substantial morbidity to the patient. Reducing infection is a research priority, but before interventional studies can be designed, the incidence of infection following this injury needs to be better defined. Our aim was to estimate the global incidence of infection following an open tibia fracture. A systematic review was performed of MEDLINE, EMBASE, Central Register of Controlled Trials (CENTRAL), Web of Science and Global Index Medicus. We included randomised controlled trials with more than ten participants which reported infections after open diaphyseal or distal fractures (AO 42 or 43). Primary outcome was deep infection according to the Centres for Disease Control and Prevention criteria. Secondary outcome included causative micro-organisms. A meta-analysis using a random effects model to assess incidence and between-treatment effects was performed. Thirteen studies including 1463 adults from seven middle-income countries, seven high-income countries and one low-income country were included. The incidence of infection was 12.12 person-years (95% CI 7.95–18.47). A subgroup analysis compared external fixation and intramedullary nailing showed no difference between infection rates. There were limited data on organisms, but Staphylococcus aureus was the most commonly identified. There are limited to no data on antimicrobial resistance.